3D tumor models: history, advances and future perspectives

P Benien, A Swami - Future oncology, 2014 - Taylor & Francis
Evaluation of cancer therapeutics by utilizing 3D tumor models, before clinical studies, could
be more advantageous than conventional 2D tumor models (monolayer cultures). The 3D …

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

MM Pomerantz, F Li, DY Takeda, R Lenci, A Chonkar… - Nature …, 2015 - nature.com
Master transcription factors interact with DNA to establish cell type identity and to regulate
gene expression in mammalian cells,. The genome-wide map of these transcription factor …

Functional implications and therapeutic targeting of androgen response elements in prostate cancer

D Senapati, V Sharma, SK Rath, U Rai, N Panigrahi - Biochimie, 2023 - Elsevier
The androgen receptor (AR) plays an essential role in the growth and progression of
prostate cancer (CaP). Ligand-activated AR inside the nucleus binds to the androgen …

Antimicrobial, antiproliferative activities and molecular docking of metabolites from Alternaria alternata

HT Khazaal, MT Khazaal, AS Abdel-Razek, AA Hamed… - AMB Express, 2023 - Springer
Endophytic fungi allied to plants have sparked substantial promise in discovering new
bioactive compounds. In this study, propagation of the endophytic fungus Alternaria …

Characterisation of cell lines derived from prostate cancer patients with localised disease

L Moya, C Walpole, F Rae, S Srinivasan… - Prostate Cancer and …, 2023 - nature.com
Background Prostate cancer is a broad-spectrum disease, spanning from indolent to a
highly aggressive lethal malignancy. Prostate cancer cell lines are essential tools to …

The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer

RJ Rebello, E Kusnadi, DP Cameron, HB Pearson… - Clinical Cancer …, 2016 - AACR
Purpose: The MYC oncogene is frequently overexpressed in prostate cancer. Upregulation
of ribosome biogenesis and function is characteristic of MYC-driven tumors. In addition, PIM …

Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients

S Belluti, V Semeghini, G Rigillo, M Ronzio… - Journal of Experimental …, 2021 - Springer
Background Approaches based on expression signatures of prostate cancer (PCa) have
been proposed to predict patient outcomes and response to treatments. The transcription …

Nerve growth factor induces proliferation and aggressiveness in prostate cancer cells

M Di Donato, G Cernera, A Migliaccio, G Castoria - Cancers, 2019 - mdpi.com
Resistance to hormone therapy and disease progression is the major challenge in clinical
management of prostate cancer (PC). Drugs currently used in PC therapy initially show a …

Deregulated microRNAs involved in prostate cancer aggressiveness and treatment resistance mechanisms

H Gujrati, S Ha, BD Wang - Cancers, 2023 - mdpi.com
Simple Summary Accumulating studies have highlighted the critical roles of microRNAs in
tumorigenesis and cancer treatment responses. Here, we systematically review the scientific …

Cancer-associated fibroblasts modify the response of prostate cancer cells to androgen and anti-androgens in three-dimensional spheroid culture

T Eder, A Weber, H Neuwirt, G Grünbacher… - International journal of …, 2016 - mdpi.com
Androgen receptor (AR) targeting remains the gold standard treatment for advanced
prostate cancer (PCa); however, treatment resistance remains a major clinical problem. To …